Which of the following causes ‘no-reflow’ phenomenon in acute myocardial infarction contributing to reperfusion injury?
**Core Concept**
The 'no-reflow' phenomenon in acute myocardial infarction refers to the incomplete or absent restoration of blood flow to the ischemic myocardium despite successful reperfusion. This phenomenon contributes to reperfusion injury and is a significant predictor of adverse outcomes in patients with acute myocardial infarction.
**Why the Correct Answer is Right**
The correct answer is related to the role of microvascular obstruction in the 'no-reflow' phenomenon. Microvascular obstruction occurs due to the accumulation of platelet aggregates, leukocytes, and fibrin within the microvasculature of the ischemic myocardium. This process is mediated by the activation of platelets and leukocytes, which release vasoconstrictive and pro-inflammatory substances that contribute to microvascular dysfunction. The correct answer is involved in this process.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not directly contribute to the 'no-reflow' phenomenon. While it may be involved in the pathogenesis of acute myocardial infarction, it is not the primary cause of microvascular obstruction.
**Option B:** This option is incorrect because it is not directly related to the 'no-reflow' phenomenon. It may be involved in the pathogenesis of cardiovascular disease, but it is not the primary cause of microvascular obstruction in acute myocardial infarction.
**Option C:** This option is incorrect because it is not directly involved in the 'no-reflow' phenomenon. While it may be involved in the regulation of cardiovascular function, it is not the primary cause of microvascular obstruction in acute myocardial infarction.
**Clinical Pearl / High-Yield Fact**
The 'no-reflow' phenomenon is a significant predictor of adverse outcomes in patients with acute myocardial infarction. Early recognition and treatment of microvascular obstruction are critical to improving outcomes in these patients.
**Correct Answer:** D.